The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks rise as BoE keeps rates on hold

Thu, 21st Mar 2024 16:33

(Sharecast News) - London markets closed higher on Thursday, sustaining gains after the Bank of England adhered to expectations by maintaining interest rates at a 16-year high.

The FTSE 100 rose 1.88%, closing at 7,882.55 points, while the FTSE 250 saw an increase of 1.32%, reaching 19,741.31 points by the end of trading.

In currency markets, sterling was last down 0.94% on the dollar to trade at $1.2665, while it decreased 0.38% against the euro to change hands at €1.1661.

"Markets have continued their euphoric reaction to this week's central bank events, with the FTSE 100 closing in on 7,900 for the first time since May last year," said IG chief market analyst Chris Beauchamp.

"UK stocks have lagged far behind, but with the Bank of England now on a path to cutting rates we could see the FTSE 350 make further strides as the flow of investor money finally heads to the UK."

Beauchamp quipped that a 'no change' policy meeting rarely produces "quite the excitement" as Wednesday night's Fed decision.

"While nodding towards stronger than expected, the Fed's decision to stick to current plans has resulted in yet more record highs for the Dow, S&P 500 and Nasdaq 100.

"Things do seem to be getting a little excessive in markets, especially since the S&P 500 has yet to register a pullback of more than 3% so far this year."

BoE maintains interest rates as services sector grows

In economic news, the Bank of England kept interest rates unchanged at 5.25%, as anticipated, following a vote by its Monetary Policy Committee.

The decision, with a majority vote of eight-to-one, marked a continuation of the 16-year high borrowing cost.

External member Swati Dhingra dissented, advocating for a 0.25 percentage point cut.

It contrasted with February's decision, when Catherine Mann and Jonathan Haskel pushed for a 25 basis point hike.

With inflation easing from its peak, currently at 3.4%, the MPC was expected to embark on rate reductions this year.

Governor Andrew Bailey highlighted positive indicators of inflation abatement but maintained a cautious approach.

"The BoE will need to see a lot more moderation in wages and services prices before it starts cutting rates," said Marion Amiot, senior European economist at S&P Global Ratings.

"We don't expect that to be before August, as the labour market remains tight.

"While vacancies are falling, the workforce is barely expanding, supporting pay increases that are well above productivity gains and the 2% inflation target."

Meanwhile, UK public-sector borrowing in February saw a significant drop, continuing a downward trend for the fourth consecutive month.

Net borrowing excluding public-sector banks stood at £8.4bn, £3.4bn lower than February 2023, indicating fiscal resilience amidst economic recovery.

Additionally, the UK service sector exhibited growth in March, though at a slower pace, hinting at an economy potentially emerging from recession.

The S&P Global flash UK composite purchasing managers' index showed a slight dip to 52.9, yet remaining above the expansion threshold of 50.0.

On the continent, eurozone business activity displayed early signs of stabilising, with the latest HCOB flash eurozone composite PMI output index reaching a nine-month high of 49.9, suggesting a tentative return to growth.

Next, Virgin Money in the green, Dowlais out of favour

On London's equity markets, fashion retailer Next jumped 6.67% after posting a better-than-expected 5% increase in annual profits to £918m, and maintaining guidance for 2024.

Direct Line Insurance Group managed 0.1% gains despite reporting widening of its full-year losses.

The company announced a new £100m cost-saving plan and reinstated its dividend, which contributed to investor confidence.

Virgin Money UK advanced 2.74% after formally agreeing to be acquired by Nationwide in a £2.9bn deal, confirming a preliminary agreement announced earlier in March.

International Airlines Group (IAG), the owner of British Airways and Iberia, saw its shares ascend 2.9% following an upgrade to 'outperform' by RBC Capital Markets.

The upgrade cited potential upside to consensus expectations for 2024.

On the downside, Schroders, British American Tobacco, Crest Nicholson, Hikma Pharmaceuticals, and Beazley all saw decreases, as they traded without entitlement to dividends.

Savings and investment firm M&G fell 3.57% despite beating analysts' forecasts with its 2023 results.

Net client flows, adjusted profits, and operating capital generation improved significantly from the previous year.

Shares in automotive engineering group Dowlais dropped sharply by 9.94% despite announcing a £50m share buyback and pointing to stable revenues in 2024.

Computacenter also experienced a decline of 1.7%, despite reporting record revenue, gross profit, and adjusted earnings per share a day earlier.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,882.55 1.88%

FTSE 250 (MCX) 19,741.31 1.32%

techMARK (TASX) 4,501.89 0.85%

FTSE 100 - Risers

St James's Place (STJ) 461.50p 10.33%

3i Group (III) 2,748.00p 8.83%

Airtel Africa (AAF) 97.75p 7.77%

Melrose Industries (MRO) 664.20p 6.99%

Next (NXT) 9,070.00p 6.98%

Halma (HLMA) 2,362.00p 6.97%

Croda International (CRDA) 5,004.00p 5.93%

JD Sports Fashion (JD.) 117.10p 5.92%

Anglo American (AAL) 1,923.80p 5.62%

Persimmon (PSN) 1,334.00p 5.62%

FTSE 100 - Fallers

Burberry Group (BRBY) 1,191.00p -3.25%

Prudential (PRU) 759.00p -2.77%

Centrica (CNA) 125.20p -2.38%

Smith & Nephew (SN.) 1,033.00p -2.36%

British American Tobacco (BATS) 2,362.00p -2.07%

Hikma Pharmaceuticals (HIK) 1,873.50p -2.06%

Reckitt Benckiser Group (RKT) 4,300.00p -1.56%

Unilever (ULVR) 3,907.00p -0.56%

Schroders (SDR) 378.80p -0.45%

Smurfit Kappa Group (CDI) (SKG) 3,584.00p -0.44%

FTSE 250 - Risers

Close Brothers Group (CBG) 398.00p 14.57%

Hochschild Mining (HOC) 124.70p 10.26%

Johnson Matthey (JMAT) 1,860.00p 8.93%

Marshalls (MSLH) 285.60p 8.59%

Mobico Group (MCG) 73.05p 8.54%

Future (FUTR) 641.00p 8.09%

TI Fluid Systems (TIFS) 169.00p 7.78%

Investec (INVP) 524.00p 6.72%

Shaftesbury Capital (SHC) 141.80p 6.70%

Genus (GNS) 1,829.00p 6.65%

FTSE 250 - Fallers

Computacenter (CCC) 2,696.00p -8.36%

Ferrexpo (FXPO) 43.74p -7.99%

Trustpilot Group (TRST) 192.50p -7.45%

Watches of Switzerland Group (WOSG) 343.60p -6.22%

Octopus Renewables Infrastructure Trust (ORIT) 72.90p -4.83%

Bytes Technology Group (BYIT) 515.50p -4.18%

Moonpig Group (MOON) 161.10p -3.88%

Bakkavor Group (BAKK) 100.50p -3.37%

Crest Nicholson Holdings (CRST) 197.00p -3.24%

Dr. Martens (DOCS) 87.05p -3.12%

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.